A pathophysiological model of freezing of gait in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 15, Issue 5, 2009, Pages 333-338

  Lewis, Simon J G ^a,b   Barker, Roger A ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Basal ganglia; Cognitive; Freezing of gait; Limbic; Motor; Oscillations; Parkinson's disease; Synchronization

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BOTULINUM TOXIN A; DOPAMINE; METHYLPHENIDATE;

BASAL GANGLION; BRAIN DEPTH STIMULATION; COGNITION; DOPAMINERGIC SYSTEM; FREEZING OF GAIT; GAIT DISORDER; HUMAN; LEWY BODY; LIMBIC SYSTEM; MOTOR PERFORMANCE; NEUROIMAGING; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; SHORT SURVEY; SUBTHALAMIC NUCLEUS; THALAMUS; WORKING MEMORY;

AGED; BASAL GANGLIA; CORPUS STRIATUM; COST OF ILLNESS; DISEASE PROGRESSION; DOPAMINE; GAIT APRAXIA; HUMANS; MIDDLE AGED; MODELS, BIOLOGICAL; MOTOR ACTIVITY; NEURODEGENERATIVE DISEASES; NURSING HOMES; PARKINSON DISEASE; QUALITY OF LIFE; WALKING;

EID: 67349172127     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.08.006     Document Type: Short Survey

References (72)

1. Jarman B., Hurwitz B., Cook A., Bajekal M., and Lee A. Effects of community based nurses specialising in Parkinson's disease on health outcome and costs: randomised controlled trial. BMJ 324 (2002) 1072-1075
2. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., and Kragh-Sorensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 56 (2001) 730-736
3. Althaus A., Arranz Becker O., Spottke A., Dengler R., Schneider F., Kloss M., et al. Frequency and treatment of depressive symptoms in a Parkinson's disease registry. Parkinsonism Relat Disord (2008 Apr 11) Epub ahead of print
4. Chaudhuri K.R., Healy D.G., Schapira A.H., and National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5 (2006) 235-245
5. Gray P., and Hildebrand K. Fall risk factors in Parkinson's disease. J Neurosci Nurs 32 (2000) 222-228
6. Aarsland D., Larsen J.P., Tandberg E., and Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J Am Geriatr Soc 48 (2000) 938-942
7. Diamond A., and Jankovic J. Treatment of advanced Parkinson's disease. Expert Rev Neurother 6 (2006) 1181-1197
8. Davis J.T., Lyons K.E., and Pahwa R. Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson's disease. Clin Neurol Neurosurg 108 (2006) 461-464
9. Devos D., Krystkowiak P., Clement F., Dujardin K., Cottencin O., Waucquier N., et al. Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 78 (2007) 470-475
10. Nieuwboer A., Kwakkel G., Rochester L., Jones D., van Wegen E., Willems A.M., et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 78 (2007) 134-140
11. Giladi N., Kao R., and Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 12 (1997) 302-305
12. Giladi N., McDermott M.P., Fahn S., Przedborski S., Jankovic J., Stern M., et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 56 (2001) 1712-1721
13. Giladi N., McMahon D., Przedborski S., Flaster E., Guillory S., Kostic V., et al. Motor blocks in Parkinson's disease. Neurology 42 (1992) 333-339
14. Lamberti P., Armenise S., Castaldo V., de Mari M., Iliceto G., Tronci P., et al. Freezing gait in Parkinson's disease. Eur Neurol 38 (1997) 297-301
15. Zetusky W.J., Jankovic J., and Pirozzolo F.J. The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 35 (1985) 522-526
16. Graham J.M., and Sagar H.J. A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes. Mov Disord 14 (1999) 10-20
17. Lewis S.J., Foltynie T., Blackwell A.D., Robbins T.W., Owen A.M., and Barker R.A. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76 (2005) 343-348
18. Kish S.J., Shannak K., and Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318 (1988) 876-880
19. Jellinger K.A. Post mortem studies in Parkinson's disease - is it possible to detect brain areas for specific symptoms?. J Neural Transm Suppl 56 (1999) 1-29
20. Giladi N., Gurevich T., Shabtai H., Paleacu D., and Simon E.S. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. J Neurol 248 (2001) 572-576
21. Wieler M., Camicioli R., Jones C.A., and Martin W.R. Botulinum toxin injections do not improve freezing of gait in Parkinson disease. Neurology 65 (2005) 626-628
22. Bartels A.L., Balash Y., Gurevich T., Schaafsma J.D., Hausdorff J.M., and Giladi N. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia. J Clin Neurosci 10 (2003) 584-588
23. Ferraye M.U., Debu B., Fraix V., Xie-Brustolin J., Chabardes S., Krack P., et al. Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease. Neurology 70 (2008) 1431-1437
24. Lyoo C.H., Aalto S., Rinne J.O., Lee K.O., Oh S.H., Chang J.W., et al. Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait. Mov Disord 22 (2007) 2176-2182
25. Stefani A., Lozano A.M., Peppe A., Stanzione P., Galati S., Tropepi D., et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 130 (2007) 1596-1607
26. Alexander G.E., DeLong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9 (1986) 357-381
27. Parent A., Sato F., Wu Y., Gauthier J., Levesque M., and Parent M. Organization of the basal ganglia: the importance of axonal collateralization. Trends Neurosci 23 (2000) S20-S27
28. DeLong M.R., and Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 64 (2007) 20-24
29. Mitchell I.J., Clarke C.E., Boyce S., Robertson R.G., Peggs D., Sambrook M.A., et al. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32 (1989) 213-226
30. Jenkins I.H., Fernandez W., Playford E.D., Lees A.J., Frackowiak R.S., Passingham R.E., et al. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine. Ann Neurol 32 (1992) 749-757
31. Playford E.D., Jenkins I.H., Passingham R.E., Nutt J., Frackowiak R.S., and Brooks D.J. Impaired mesial frontal and putamen activation in Parkinson's disease: a positron emission tomography study. Ann Neurol 32 (1992) 151-161
32. Bergman H., Wichmann T., Karmon B., and DeLong M.R. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72 (1994) 507-520
33. Jahanshahi M., Jenkins I.H., Brown R.G., Marsden C.D., Passingham R.E., and Brooks D.J. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Brain 118 (1995) 913-933
34. Lee M.S., Rinne J.O., and Marsden C.D. The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med J 41 (2000) 167-184
35. Pahapill P.A., and Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 123 (2000) 1767-1783
36. Zweig R.M., Jankel W.R., Hedreen J.C., Mayeux R., and Price D.L. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 26 (1989) 41-46
37. Plaha P., and Gill S.S. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 16 (2005) 1883-1887
38. Mazzone P., Lozano A., Stanzione P., Galati S., Scarnati E., Peppe A., et al. Implantation of human pedunculopontine nucleus: a safe and clinically relevant target in Parkinson's disease. Neuroreport 16 (2005) 1877-1881
39. Jenkinson N., Nandi D., Oram R., Stein J.F., and Aziz T.Z. Pedunculopontine nucleus electric stimulation alleviates akinesia independently of dopaminergic mechanisms. Neuroreport 17 (2006) 639-641
40. Nandi D., Aziz T.Z., Giladi N., Winter J., and Stein J.F. Reversal of akinesia in experimental parkinsonism by GABA antagonist microinjections in the pedunculopontine nucleus. Brain 125 (2002) 2418-2430
41. Lees A.J., and Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 106 (1983) 257-270
42. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., and Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 114 (1991) 2095-2122
43. Brown P., and Marsden C.D. What do the basal ganglia do?. Lancet 351 (1998) 1801-1804
44. Lauterbach E.C. The neuropsychiatry of Parkinson's disease. Minerva Med 96 (2005) 155-173
45. Farley B., Fox C., Ramig L., and McFarland D. Intensive amplitude-specific therapeutic approaches for Parkinson's Disease: toward a neuroplasticity-principled rehabilitation model. Topics Geriatr Rehabil 24 (2008) 99-114
46. Amboni M., Cozzolino A., Longo K., Picillo M., and Barone P. Freezing of gait and executive functions in patients with Parkinson's disease. Mov Disord 23 (2008) 395-400
47. Robertson C., and Flowers K.A. Motor set in Parkinson's disease. J Neurol Neurosurg Psychiatry 53 (1990) 583-592
48. Cools A.R., van den Bercken J.H., Horstink M.W., van Spaendonck K.P., and Berger H.J. Cognitive and motor shifting aptitude disorder in Parkinson's disease. J Neurol Neurosurg Psychiatry 47 (1984) 443-453
49. Owen A.M., Roberts A.C., Hodges J.R., Summers B.A., Polkey C.E., and Robbins T.W. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain 116 (1993) 1159-1175
50. Cools R., Barker R.A., Sahakian B.J., and Robbins T.W. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 124 (2001) 2503-2512
51. Williams-Gray C.H., Foltynie T., Brayne C.E., Robbins T.W., and Barker R.A. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130 (2007) 1787-1798
52. Morris R.G., Downes J.J., Sahakian B.J., Evenden J.L., Heald A., and Robbins T.W. Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 51 (1988) 757-766
53. Middleton F.A., and Strick P.L. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 42 (2000) 183-200
54. Stamm J.S. Electrical stimulation of monkeys' prefrontal cortex during delayed-response performance. J Comp Physiol Psychol 67 (1969) 535-546
55. Marie R.M., Barre L., Dupuy B., Viader F., Defer G., and Baron J.C. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 260 (1999) 77-80
56. Lewis S.J., Dove A., Robbins T.W., Barker R.A., and Owen A.M. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 23 (2003) 6351-6356
57. Lewis S.J., Dove A., Robbins T.W., Barker R.A., and Owen A.M. Striatal contributions to working memory: a functional magnetic resonance imaging study in humans. Eur J Neurosci 19 (2004) 755-760
58. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
59. Grace A.A., Floresco S.B., Goto Y., and Lodge D.J. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci 30 (2007) 220-227
60. Gatev P., Darbin O., and Wichmann T. Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov Disord 21 (2006) 1566-1577
61. Kuhn A.A., Kupsch A., Schneider G.H., and Brown P. Reduction in subthalamic 8-35 Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur J Neurosci 23 (2006) 1956-1960
62. Rolls E.T., Thorpe S.J., and Maddison S.P. Responses of striatal neurons in the behaving monkey. 1. Head of the caudate nucleus. Behav Brain Res 7 (1983) 179-210
63. Brown P., and Williams D. Basal ganglia local field potential activity: character and functional significance in the human. Clin Neurophysiol 116 (2005) 2510-2519
64. Hammond C., Bergman H., and Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 30 (2007) 357-364
65. Skinner R.D., and Garcia-Rill E. The mesencephalic locomotor region (MLR) in the rat. Brain Res 323 (1984) 385-389
66. Skinner R.D., Kinjo N., Henderson V., and Garcia-Rill E. Locomotor projections from the pedunculopontine nucleus to the spinal cord. Neuroreport 1 (1990) 183-186
67. Albani G., Sandrini G., Kunig G., Martin-Soelch C., Mauro A., Pignatti R., et al. Differences in the EMG pattern of leg muscle activation during locomotion in Parkinson's disease. Funct Neurol 18 (2003) 165-170
68. Nieuwboer A., Dom R., De Weerdt W., Desloovere K., Janssens L., and Stijn V. Electromyographic profiles of gait prior to onset of freezing episodes in patients with Parkinson's disease. Brain 127 (2004) 1650-1660
69. Alice N., Fabienne C., Anne-Marie W., and Kaat D. Does freezing in Parkinson's disease change limb coordination? A kinematic analysis. J Neurol 254 (2007) 1268-1277
70. Fabre N., Brefel C., Sabatini U., Celsis P., Montastruc J.L., Chollet F., et al. Normal frontal perfusion in patients with frozen gait. Mov Disord 13 (1998) 677-683
71. Matsui H., Udaka F., Miyoshi T., Hara N., Tamaura A., Oda M., et al. Three-dimensional stereotactic surface projection study of freezing of gait and brain perfusion image in Parkinson's disease. Mov Disord 20 (2005) 1272-1277
72. Bartels A.L., de Jong B.M., Giladi N., Schaafsma J.D., Maguire R.P., Veenma L., et al. Striatal dopa and glucose metabolism in PD patients with freezing of gait. Mov Disord 21 (2006) 1326-1332